» Articles » PMID: 24741043

Cannabis Use is Quantitatively Associated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users

Overview
Journal J Neurosci
Specialty Neurology
Date 2014 Apr 18
PMID 24741043
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

Marijuana is the most commonly used illicit drug in the United States, but little is known about its effects on the human brain, particularly on reward/aversion regions implicated in addiction, such as the nucleus accumbens and amygdala. Animal studies show structural changes in brain regions such as the nucleus accumbens after exposure to Δ9-tetrahydrocannabinol, but less is known about cannabis use and brain morphometry in these regions in humans. We collected high-resolution MRI scans on young adult recreational marijuana users and nonusing controls and conducted three independent analyses of morphometry in these structures: (1) gray matter density using voxel-based morphometry, (2) volume (total brain and regional volumes), and (3) shape (surface morphometry). Gray matter density analyses revealed greater gray matter density in marijuana users than in control participants in the left nucleus accumbens extending to subcallosal cortex, hypothalamus, sublenticular extended amygdala, and left amygdala, even after controlling for age, sex, alcohol use, and cigarette smoking. Trend-level effects were observed for a volume increase in the left nucleus accumbens only. Significant shape differences were detected in the left nucleus accumbens and right amygdala. The left nucleus accumbens showed salient exposure-dependent alterations across all three measures and an altered multimodal relationship across measures in the marijuana group. These data suggest that marijuana exposure, even in young recreational users, is associated with exposure-dependent alterations of the neural matrix of core reward structures and is consistent with animal studies of changes in dendritic arborization.

Citing Articles

The Impacts of Adolescent Cannabinoid Exposure on Striatal Anxiety- and Depressive-Like Pathophysiology Are Prevented by the Antioxidant -Acetylcysteine.

De Felice M, Szkudlarek H, Uzuneser T, Rodriguez-Ruiz M, Sarikahya M, Pusparajah M Biol Psychiatry Glob Open Sci. 2024; 4(6):100361.

PMID: 39257692 PMC: 11381987. DOI: 10.1016/j.bpsgos.2024.100361.


Amygdala volume and depression symptoms in young adolescents who use cannabis.

Wallace A, Huestis M, Sullivan R, Wade N Behav Brain Res. 2024; 472:115150.

PMID: 39009188 PMC: 11656890. DOI: 10.1016/j.bbr.2024.115150.


Global public concern of childhood and adolescence suicide: a new perspective and new strategies for suicide prevention in the post-pandemic era.

Kim S, Park J, Lee H, Lee H, Woo S, Kwon R World J Pediatr. 2024; 20(9):872-900.

PMID: 39008157 DOI: 10.1007/s12519-024-00828-9.


Hippocampal gray matter volume in young adulthood varies with adolescent alcohol use.

Purcell J, Harnett N, Mrug S, Elliott M, Tortolero Emery S, Schuster M Exp Clin Psychopharmacol. 2024; 32(5):566-578.

PMID: 38753392 PMC: 11826516. DOI: 10.1037/pha0000722.


Macroscopic and Microscopic Cerebral Findings in Drug and Alcohol Abusers: The Point of View of the Forensic Pathologist.

Montana A, Alfieri L, Neri M, Piano D, Renier E, Marti M Biomedicines. 2024; 12(3).

PMID: 38540294 PMC: 10968460. DOI: 10.3390/biomedicines12030681.


References
1.
Makris N, Gasic G, Kennedy D, Hodge S, Kaiser J, Lee M . Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse?. Neuron. 2008; 60(1):174-88. PMC: 3772717. DOI: 10.1016/j.neuron.2008.08.011. View

2.
Matochik J, Eldreth D, Cadet J, Bolla K . Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend. 2004; 77(1):23-30. DOI: 10.1016/j.drugalcdep.2004.06.011. View

3.
Gilman J, Ramchandani V, Davis M, Bjork J, Hommer D . Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol. J Neurosci. 2008; 28(18):4583-91. PMC: 2730732. DOI: 10.1523/JNEUROSCI.0086-08.2008. View

4.
Quickfall J, Crockford D . Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci. 2006; 18(3):318-32. DOI: 10.1176/jnp.2006.18.3.318. View

5.
Karschner E, Darwin W, McMahon R, Liu F, Wright S, Goodwin R . Subjective and physiological effects after controlled Sativex and oral THC administration. Clin Pharmacol Ther. 2011; 89(3):400-7. PMC: 3836266. DOI: 10.1038/clpt.2010.318. View